Cargando…

Improving Adherence to Weight‐Loss Medication (Liraglutide 3.0 mg) Using Mobile Phone Text Messaging and Healthcare Professional Support

BACKGROUND: Adherence to weight‐loss medication is suboptimal, leading to poor health outcomes. Short message service (SMS) can potentially improve adherence. METHODS: A total of 3,994 participants with overweight or obesity in Australia receiving Saxenda® (liraglutide 3.0 mg) were enrolled from Sep...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Ang, Cunich, Michelle, Fuller, Nicholas, Purcell, Katrina, Flynn, Allanah, Caterson, Ian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589266/ https://www.ncbi.nlm.nih.gov/pubmed/32902905 http://dx.doi.org/10.1002/oby.22930

Ejemplares similares

Adherence to and Dropout from Liraglutide 3.0 mg Obesity Treatment in a Real-World Setting
por: Ko, Hae-Jin, et al.
Publicado: (2022)

Exposure–response analyses of liraglutide 3.0 mg for weight management
por: Wilding, J. P. H., et al.
Publicado: (2016)

Liraglutide 3.0 mg for Weight Management: A Population Pharmacokinetic Analysis
por: Overgaard, Rune V., et al.
Publicado: (2016)

Mobile phone text messaging for promoting adherence to anti-tuberculosis treatment: a systematic review
por: Nglazi, Mweete D, et al.
Publicado: (2013)

Economic evaluation of mobile phone text message interventions to improve adherence to HIV therapy in Kenya
por: Patel, Anik R., et al.
Publicado: (2017)

Real‐World Clinical Effectiveness of Liraglutide 3.0 mg for Weight Management in Canada
por: Wharton, Sean, et al.
Publicado: (2019)

Liraglutide 3.0 mg and mental health: can psychiatric symptoms be associated to adherence to therapy? Insights from a clinical audit
por: Tempia Valenta, Silvia, et al.
Publicado: (2023)

Mobile phone text messaging for promoting adherence to anti-tuberculosis treatment: a systematic review protocol
por: Nglazi, Mweete D, et al.
Publicado: (2013)

The burden of obesity in the current world and the new treatments available: focus on liraglutide 3.0 mg
por: Mancini, Marcio C., et al.
Publicado: (2017)

A pilot randomized controlled trial of liraglutide 3.0 mg for binge eating disorder
por: Allison, Kelly C., et al.
Publicado: (2022)

Mobile Phone Text Messaging: Tool for Malaria Control in Africa
por: Zurovac, Dejan, et al.
Publicado: (2012)

The Effectiveness of Mobile Phone Text Messaging in Improving Medication Adherence for Patients with Chronic Diseases: A Systematic Review
por: Ershad Sarabi, Roghayeh, et al.
Publicado: (2016)

Improvements in health‐related quality of life with liraglutide 3.0 mg compared with placebo in weight management
por: Kolotkin, R. L., et al.
Publicado: (2016)

The Efficacy and Safety of Liraglutide 3.0 mg for Weight Management in Obese Non-Diabetic Saudi Outpatients
por: Albaker, Waleed, et al.
Publicado: (2021)

Text Messaging and Mobile Phone Apps as Interventions to Improve Adherence in Adolescents With Chronic Health Conditions: A Systematic Review
por: Badawy, Sherif M, et al.
Publicado: (2017)

Using mobile phone text messaging for malaria surveillance in rural Kenya
por: Githinji, Sophie, et al.
Publicado: (2014)

Mobile-phone text messaging to promote ideal cardiovascular health in women
por: Acevedo, Monica, et al.
Publicado: (2023)

Weight loss and persistence with liraglutide 3.0 mg by obesity class in the real‐world effectiveness study in Canada
por: Wharton, Sean, et al.
Publicado: (2020)

Real‐world persistence with liraglutide 3.0 mg for weight management and the SaxendaCare® patient support program
por: Wharton, Sean, et al.
Publicado: (2020)

Liraglutide 3.0 mg for the management of insufficient weight loss or excessive weight regain post‐bariatric surgery
por: Wharton, Sean, et al.
Publicado: (2019)

Efficacy of liraglutide 3.0 mg treatment on weight loss in patients with weight regain after bariatric surgery
por: Muratori, Fabrizio, et al.
Publicado: (2022)

Marked weight loss on liraglutide 3.0 mg: Real‐life experience of a Swiss cohort with obesity
por: Santini, Sara, et al.
Publicado: (2022)

Mobile phone text messages for improving adherence to antiretroviral therapy (ART): an individual patient data meta-analysis of randomised trials
por: Mbuagbaw, Lawrence, et al.
Publicado: (2013)

Impact of Treatment with GLP1 Receptor Agonists, Liraglutide 3.0 mg and Semaglutide 1.0 mg, While on a Waiting List for Bariatric Surgery
por: Rubio-Herrera, Miguel A., et al.
Publicado: (2023)

SAT-097 Weight Loss With Liraglutide 3.0 Mg Versus Placebo For Individuals Who Adhere To The Trial Drug: A Secondary Analysis From SCALE IBT
por: Shaw Tronieri, Jena, et al.
Publicado: (2019)

Effect of a smartphone application (Perx) on medication adherence and clinical outcomes: a 12-month randomised controlled trial
por: Li, Ang, et al.
Publicado: (2021)

The effect of mobile phone text-message reminders on Kenyan health workers' adherence to malaria treatment guidelines: a cluster randomised trial
por: Zurovac, Dejan, et al.
Publicado: (2011)

The Cameroon Mobile Phone SMS (CAMPS) Trial: A Randomized Trial of Text Messaging versus Usual Care for Adherence to Antiretroviral Therapy
por: Mbuagbaw, Lawrence, et al.
Publicado: (2012)

Costs and Cost-Effectiveness of a Mobile Phone Text-Message Reminder Programmes to Improve Health Workers' Adherence to Malaria Guidelines in Kenya
por: Zurovac, Dejan, et al.
Publicado: (2012)

Impact of mobile phone text messaging intervention on adherence among patients with diabetes in a rural setting: A randomized controlled trial
por: Owolabi, Eyitayo Omolara, et al.
Publicado: (2020)

Improving Retention in Care and Promoting Adherence to HIV Treatment: Protocol for a Multisite Randomized Controlled Trial of Mobile Phone Text Messaging
por: Tanue, Elvis Asangbeng, et al.
Publicado: (2020)

Mobile phone text messaging for improving the uptake of vaccinations: a systematic review protocol
por: Kalan, Robyn, et al.
Publicado: (2014)

Effect of Mobile Phone Short Text Messages on Glycemic Control in Type 2 Diabetes
por: Bin Abbas, Bassam, et al.
Publicado: (2015)

Early Weight Loss with Liraglutide 3.0 mg Predicts 1‐Year Weight Loss and is Associated with Improvements in Clinical Markers
por: Fujioka, Ken, et al.
Publicado: (2016)

Liraglutide 3.0 mg and Intensive Behavioral Therapy (IBT) for Obesity in Primary Care: The SCALE IBT Randomized Controlled Trial
por: Wadden, Thomas A., et al.
Publicado: (2020)

Efficacy and Safety of Liraglutide 3.0 mg in Patients with Overweight and Obese with or without Diabetes: A Systematic Review and Meta-Analysis
por: Konwar, Mahanjit, et al.
Publicado: (2022)

Mobile phone text messages for improving adherence to antiretroviral therapy (ART): a protocol for an individual patient data meta-analysis of randomised trials
por: Mbuagbaw, Lawrence, et al.
Publicado: (2013)

Promoting adherence to treatment for latent TB infection through mobile phone text messaging: study protocol for a pilot randomized controlled trial
por: Oren, Eyal, et al.
Publicado: (2017)

One-Way and Two-Way Mobile Phone Text Messages for Treatment Adherence Among Patients With HIV: Protocol for a Randomized Controlled Trial
por: Nsagha, Dickson Shey, et al.
Publicado: (2020)

Treatment Adherence among HIV and TB Patients Using Single and Double Way Mobile Phone Text Messages: A Randomized Controlled Trial
por: Kibu, Odette Dzemo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gb7anfcc7u2o92973onroc54tk